ID A0A0E0MRS4_ORYRU Unreviewed; 1555 AA.
AC A0A0E0MRS4;
DT 27-MAY-2015, integrated into UniProtKB/TrEMBL.
DT 27-MAY-2015, sequence version 1.
DT 24-JAN-2024, entry version 34.
DE RecName: Full=Tower domain-containing protein {ECO:0000259|SMART:SM01341};
OS Oryza rufipogon (Brownbeard rice) (Asian wild rice).
OC Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC Spermatophyta; Magnoliopsida; Liliopsida; Poales; Poaceae; BOP clade;
OC Oryzoideae; Oryzeae; Oryzinae; Oryza.
OX NCBI_TaxID=4529 {ECO:0000313|EnsemblPlants:ORUFI01G04350.2, ECO:0000313|Proteomes:UP000008022};
RN [1] {ECO:0000313|Proteomes:UP000008022}
RP NUCLEOTIDE SEQUENCE.
RC STRAIN=cv. W1943 {ECO:0000313|Proteomes:UP000008022};
RA Zhao Q.;
RL Submitted (JUN-2013) to the EMBL/GenBank/DDBJ databases.
RN [2] {ECO:0000313|EnsemblPlants:ORUFI01G04350.2}
RP IDENTIFICATION.
RG EnsemblPlants;
RL Submitted (JUN-2015) to UniProtKB.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EnsemblPlants; ORUFI01G04350.2; ORUFI01G04350.2; ORUFI01G04350.
DR Gramene; ORUFI01G04350.2; ORUFI01G04350.2; ORUFI01G04350.
DR Proteomes; UP000008022; Unassembled WGS sequence.
DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR GO; GO:0000724; P:double-strand break repair via homologous recombination; IEA:InterPro.
DR CDD; cd04493; BRCA2DBD_OB1; 1.
DR CDD; cd04494; BRCA2DBD_OB2; 1.
DR Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 4.
DR InterPro; IPR015525; BRCA2.
DR InterPro; IPR015252; BRCA2_hlx.
DR InterPro; IPR036315; BRCA2_hlx_sf.
DR InterPro; IPR015187; BRCA2_OB_1.
DR InterPro; IPR048262; BRCA2_OB_2_dom.
DR InterPro; IPR002093; BRCA2_repeat.
DR InterPro; IPR012340; NA-bd_OB-fold.
DR InterPro; IPR015205; Tower_dom.
DR PANTHER; PTHR11289:SF0; BREAST CANCER TYPE 2 SUSCEPTIBILITY PROTEIN; 1.
DR PANTHER; PTHR11289; BREAST CANCER TYPE 2 SUSCEPTIBILITY PROTEIN BRCA2; 1.
DR Pfam; PF09169; BRCA-2_helical; 1.
DR Pfam; PF09103; BRCA-2_OB1; 1.
DR Pfam; PF00634; BRCA2; 6.
DR SMART; SM01341; Tower; 1.
DR SUPFAM; SSF81872; BRCA2 helical domain; 1.
DR SUPFAM; SSF81878; BRCA2 tower domain; 1.
DR SUPFAM; SSF50249; Nucleic acid-binding proteins; 3.
DR PROSITE; PS50138; BRCA2_REPEAT; 4.
PE 4: Predicted;
KW DNA damage {ECO:0000256|ARBA:ARBA00022763};
KW DNA recombination {ECO:0000256|ARBA:ARBA00023172};
KW DNA repair {ECO:0000256|ARBA:ARBA00023204};
KW DNA-binding {ECO:0000256|ARBA:ARBA00023125};
KW Reference proteome {ECO:0000313|Proteomes:UP000008022};
KW Repeat {ECO:0000256|ARBA:ARBA00022737}.
FT DOMAIN 1171..1211
FT /note="Tower"
FT /evidence="ECO:0000259|SMART:SM01341"
FT REGION 1..68
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 439..465
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 741..778
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 1032..1054
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 20..42
FT /note="Pro residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 1555 AA; 169754 MW; 4137F5CB901BF5C6 CRC64;
MQRRWQVWGK PDGSLVWVPA SDGPPPPAAA ASEAPLPRPD PQPAATELGE ARSGDAIPEG
PGAADGCSVP SMADLFNQAL DKLVAADGMA EAIEDSGKGA VFCTGLGGSV AVSERAVERA
KALVGEVAEE ISNERRQPFG DGSNLECGLG ESNVSFKGGV HKDSLSPMFQ TGSGKMVSLS
KGSIQKARAV LEGNAENSSV IAVQSMFHTG LVRPDPVSRS STDNAMTVLE GQTNPKQGDV
ADVYDKENFP LFQTGSGKAV SVSVASIQKA KAVLEQNNTE NTEDFGRPDQ SLIFQTGSRR
PVLISERSSS VVKDGGAENI VFQTGLGRPV VVSQTSIQKA RTVLDQECAK RSGHGDTNVS
TTTFQTETPT SVLMSGGLTM NDRSVTPEGG VSMQGNFLEA DGHLPLFQTG LGRSISVSKG
SIKRASALLE PRNITKELED EAHSDDGCAT PMFKTGSGRS ITASENSRKK AHVVLEGEEP
VKNVNNDTGE AIAPMLHAGM QKFAPQNRNS SHKAITLMEQ GSSMKEEYID RGNEPPMFRT
GSGKSVLISH SSVQKARAVL EEEGNMKKEN HKQLSNVDRY IPIFTSPLKT SYARTVHISS
VGVSRAATLL GLEENTLSTQ LLGHVGDKLG TKITVERENS EHQFGVASVS GISGGCPISS
GPAENQVLMD PHQHFAFSKT TFSDSSEQAI RFSTAGGRTM AISSDALQRA KNLLGESDLE
VSPNNLLGHS SASACKENIQ NSTGLRKEGE PDLLKSRGNS KTEPAQFSIP AKPDRKHTDS
LEYAVPDATL ANGNSVRLHA ARDFHPINEI PKISKPSSRC SFGTENASDT KDKARRLQMP
SGPLIDITNY IGTHSVNTDY LAGEKRRFGG RNSISPFKRP RSSRCTIFFT LLTYNSCDQT
EDVTDEVKLM DAKKAEKYKF KTDTGAEEFQ KMLLACGASL TYTTKEWVSN HYKWIVWKLA
SLERCYPTRA AGKFLKVGNV LEELKYRYDR EVNNGHRSAI KKILEGNASP SLMMVLCISA
IYSCPDLNNS KPEDDRAHTD DDNSENKSLR PAKRNMSTKI ELTDGWYSLD ASLDLALLEQ
LEKRKLFIGQ KLRIWGASLC GWAGPVSFHE ASGTVKLMIH INGTYRARWD ETLGLCKHAG
VPLAFKCIKA SGGRVPRTLV GVTRIYPVMY RERFSDGRFV VRSERMERKA LQLYHQRVSK
IAEDIQSEHG EHCDNTDDND EGAKICKMLE RAAEPEILMS SMNSEQLLSF SYYQEKQKIV
RQNEVAKKVE NALKVAGLSS RDVTPFLKVR VTGLISKHSA TKSGCREGLI TIWNPTEKQK
SDLVEGQIYS VTGLLASSYF TEVSYLSGRG SSTAWTPLAT AQTTNFEPFF TPRKAVELSH
FGEVPLTSEF DIAGVILYVG NVYLLNNQNR QWLFLTDGSK FISGEKYEEQ DDCLLAVSFS
SKTTGEDSAF FNYALSGHIV GFSNLVKRDK DQMRHVWVAE ATESSTYSLS HEIPKKSHLK
EAATSAEKWA SNSHPMIQHL KERVLQIVGD SGRDWHVEGQ ISGFGHEISC WRGNG
//